<DOC>
	<DOCNO>NCT01314261</DOCNO>
	<brief_summary>The purpose study assess safety , pharmacokinetics , 4-week rapid virologic response ( RVR ) 3 different dos ABT-267 ( also know ombitasvir ) combination pegylated interferon/ribavirin ( pegIFN/RBV ) compare pegIFN/RBV alone ( ABT-267 placebo ) treatment naïve , hepatitis C virus ( HCV ) , genotype 1-infected participant .</brief_summary>
	<brief_title>Study ABT-267 Treatment Naive Hepatitis C Virus ( HCV ) Genotype 1 Infected Subjects</brief_title>
	<detailed_description>The study randomize , double blind , placebo control study consist 2 substudies . In substudy 1 , participant receive 1 3 dos ABT-267 placebo + pegIFN/RBV 12 week . In substudy 2 , participant receive pegIFN/RBV 36 week . Participants follow 48 week post ABT-267 treatment evaluation efficacy safety .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Treatment naïve participant Females must either postmenopausal least 2 year surgically sterile Males must surgically sterile practice specific form birth control Chronic hepatitis C virus ( HCV ) , genotype1 infected participant Documented FibroTest score combination Aspartate Aminotransferase Platelet Ratio Index ( APRI ) , liver biopsy within last 12 month document absence cirrhosis Pregnant breastfeed female Use medication contraindicate use pegylated interferon ( pegIFN ) ribavirin ( RBV ) 2 week prior study drug administration 10 halflives , whichever longer Clinically significant cardiac , respiratory ( except mild asthma ) , renal , gastrointestinal , hematologic , neurologic disease , uncontrolled medical illness psychiatric disease disorder Current past clinical evidence cirrhosis bridge fibrosis Abnormal screen laboratory result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>